Electrocardiogram in General Practice : the EGG Study

Overview

Existing resources to assist interpretation of ElectroCardioGram (ECG) in general practice provide specialized and comprehensive reading based on pathologies and ElectroCardioGram (ECG) signs rather than ElectroCardioGram (ECG) indications. Describing practices in general medicine could help prioritize the relevance of clinical and ECG signs for the general practitioner, enabling to adjust the reading given the context.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: October 1, 2021

Detailed Description

The primary objective of this study is to describe the clinical signs and ElectroCardioGram (ECG) in situations indicating an ElectroCardioGram (ECG) in general practice.

Interventions

  • Diagnostic Test: ElectroCardioGram (ECG)
    • Collection of results ElectroCardioGram (ECG).

Arms, Groups and Cohorts

  • Patient with indication of ElectroCardioGram (ECG)
    • Patient with indication of ElectroCardioGram (ECG) will be included. They will have a collection of results ElectroCardioGram (ECG).

Clinical Trial Outcome Measures

Primary Measures

  • Description of clinical signs
    • Time Frame: day 0
    • Prevalence of each clinical sign within each Electrocardiogram indication
  • Description of clinical signs ElectroCardioGram (ECG) sign
    • Time Frame: day 0
    • Prevalence of each sign on the Electrocardiogram within each indication.

Secondary Measures

  • Difficulties in carrying out the Electrocardiogram
    • Time Frame: Day 0
    • Duration of the Electrocardiogram (minutes) Measured by average duration of the ECG, prevalence of the difficulties of realization and interpretation mentioned by the investigators.
  • Initial management types
    • Time Frame: Months 1
    • Prevalence of initial management types (certificate, medication, addressing) at 1 month.
  • Diagnosis types
    • Time Frame: Months 1
    • Prevalence of diagnosis types at 1 month.

Participating in This Clinical Trial

Inclusion Criteria

  • Patient consulting one of the generalist practitioner investigators – In doctor's office or at home, scheduled or not, – During normal surgery hours or out-of-hours service, – Whatever the reason for consultation, – Aged 18 years or older, – Having an indication of ElectroCardioGram (ECG) and/or request certificate of non-contra-indication to the practice of physical activity certificate of non-contra-indication to the practice of physical activity Exclusion Criteria:

  • ElectroCardioGram (ECG) not performed due to emergency context – Patient with cognitive impairment who cannot give consent to participate in the study and / or patient under guardianship

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Centre Hospitalier Universitaire de Saint Etienne
  • Collaborator
    • Association CNGE IRMG
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Paul FRAPPE, MD, Principal Investigator, CHU DE SAINT-ETIENNE

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.